Evaluation of tumor-associated glycoprotein-72 and CA 125 serum markers in patients with gynecologic diseases
- 1 November 1994
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 171 (5) , 1183-1191
- https://doi.org/10.1016/0002-9378(94)90129-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. A lingitudinal studyCancer, 1991
- Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer.BMJ, 1989
- The CA 125 tumour-associated antigen: a review of the literatureHuman Reproduction, 1989
- An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinomaGynecologic Oncology, 1988
- Serum levels of six tumor markers in patients with benign and malignant gynecological diseaseArchiv für Gynäkologie, 1988
- Combination assay of CA125, TPA, IAP, CEA, and ferritin in serum for ovarian cancerGynecologic Oncology, 1988
- Monoclonal Antibody B72.3 Reactivity with Human EndometriumInternational Journal of Gynecological Pathology, 1987
- Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1985
- Common Epithelial Cancer of the OvaryNew England Journal of Medicine, 1985
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983